Skip to main content
Fig. 1 | BMC Cancer

Fig. 1

From: Changes in vitamin D and calcium metabolism markers in patients undergoing adjuvant chemotherapy for breast cancer

Fig. 1

Cumulative number (A and C) and percentage (B and D) of patients with EBS with at least one occurrence of hypercalciuria during chemotherapy. In A and B, patients were divided in two groups (vitamin D sufficient, n = 16, and insufficient, n = 66) using the baseline serum vitamin D level cut-off of 30 ng/mL (75 nmol/L). C and D present the same data for the whole population (n = 82)

Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us